Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,529
Closed -$507K 1394
2025
Q2
$507K Sell
22,529
-714
-3% -$14.7K 0.01% 394
2025
Q1
$485K Buy
23,243
+8,063
+53% +$169K 0.01% 392
2024
Q4
$323K Buy
15,180
+7,990
+111% +$175K 0.01% 432
2024
Q3
$167K Buy
7,190
+1,525
+27% +$35.8K ﹤0.01% 508
2024
Q2
$126K Buy
5,665
+3,340
+144% +$71.3K ﹤0.01% 528
2024
Q1
$51.2K Buy
2,325
+1,980
+574% +$40.2K ﹤0.01% 677
2023
Q4
$6.44K Buy
+345
New +$6.27K ﹤0.01% 995
2023
Q1
Sell
-685
Closed -$11K 1188
2022
Q4
$11K Buy
+685
New +$10.4K ﹤0.01% 931

Other funds holding IX

WhitTier Trust Company's IX Position: Q3 2025 in Review

WhitTier Trust Company sold out of ORIX (IX) in Q3 2025, closing a stake of 22,529 shares — an estimated $507K sold.

WhitTier Trust Company first reported a position in IX in Q4 2022 and held it in 8 quarters. The position peaked at $507K in Q2 2025. 217 funds tracked by Wall St. Rank hold IX as of Q3 2025.

  • WhitTier Trust Company reported no remaining ORIX position as of Q3 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 22,529 ORIX shares in Q3 2025, an estimated $507K.
  • WhitTier Trust Company first reported a position in ORIX in Q4 2022 and held it in 8 quarters.
  • WhitTier Trust Company's ORIX position peaked at $507K in Q2 2025.
  • 217 funds tracked by Wall St. Rank held ORIX as of Q3 2025.

Based on WhitTier Trust Company's 13F filing for Q3 2025, filed 31 Oct 2025.